Free Trial

Getinge (OTCMKTS:GNGBY) Shares Gap Down - Here's What Happened

Getinge logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped down: Getinge closed at $21.56 and opened at $20.65 on Friday, with the last trade at $20.65 on light volume of 7,780 shares.
  • Recent quarter and valuation: Getinge reported $0.47 EPS and $1.08 billion in revenue for the quarter, and the company has a market cap of $5.62 billion with a P/E of 23.98.
  • Balance sheet and technicals: The company shows moderate leverage and liquidity (debt/equity 0.27, current ratio 1.32) and the 50‑day moving average ($20.92) sits below the 200‑day average ($22.22), indicating recent relative weakness.
  • Five stocks we like better than Getinge.

Getinge (OTCMKTS:GNGBY - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $21.56, but opened at $20.65. Getinge shares last traded at $20.65, with a volume of 7,780 shares trading hands.

Getinge Trading Up 0.9%

The company has a market cap of $5.62 billion, a price-to-earnings ratio of 23.98 and a beta of 1.10. The business's fifty day moving average price is $20.92 and its 200 day moving average price is $22.22. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.32 and a quick ratio of 0.86.

Getinge (OTCMKTS:GNGBY - Get Free Report) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $0.47 EPS for the quarter. The company had revenue of $1.08 billion for the quarter. Getinge had a net margin of 6.54% and a return on equity of 10.60%.

Getinge Company Profile

(Get Free Report)

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company's offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge's solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company's product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Getinge Right Now?

Before you consider Getinge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Getinge wasn't on the list.

While Getinge currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines